Benitec Biopharma (BNTC)

• Market cap: $365M
• 1 day: -13.05%
• 5 days: -16.23%
• 1 month: -20.25%
• 3 months: -21.24%
• 6 months: -30.12%
• Year to date: -10.68%
• 1 year: -15.51%
• 5 years: -77.96%
• 10 years: -99.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19